Reductions in all-cause, cancer, and coronary mortality in statin-treated patients with heterozygous familial hypercholesterolaemia: A prospective registry study

Andrew Neil, Jackie Cooper, John Betteridge, Nigel Capps, Ian McDowell, Paul Durrington, Mary Seed, Steve E. Humphries

    Research output: Contribution to journalArticlepeer-review

    Abstract

    Aims: To examine the changes in coronary, all-cause, and cancer mortality in patients with heterozygous familial hypercholesterolaemia (FH) before and after lipid-lowering therapy with statins. Methods and results: A total of 3382 patients (1650 men) aged
    Original languageEnglish
    Pages (from-to)2625-2633
    Number of pages8
    JournalEuropean Heart Journal
    Volume29
    Issue number21
    DOIs
    Publication statusPublished - Nov 2008

    Keywords

    • All-cause mortality
    • Cancer mortality
    • Coronary heart disease
    • Familial hypercholesterolaemia

    Fingerprint

    Dive into the research topics of 'Reductions in all-cause, cancer, and coronary mortality in statin-treated patients with heterozygous familial hypercholesterolaemia: A prospective registry study'. Together they form a unique fingerprint.

    Cite this